Focus on drug resistance of cancer, there were also several studies that demonstrated that USP10 participated in cisplatin resistance of osteosarcoma cells, colon cancer cells, cervical cancer cells, and non-small cell lung cancer cells (Annibaldi et al. 2011; Hu et al. 2020). Here, USP10 is linked to cervical carcinoma.